Clinical and pharmacological group: & nbsp

Vaccines, serums, phages and toxoids

Included in the formulation
Included in the list (Order of the Government of the Russian Federation No. 2782-r of 30.12.2014):

VED

АТХ:

J.07.B.B.02   Influenza virus - purified antigen

J.07.B.B   Vaccine for the prevention of influenza

Pharmacodynamics:

The vaccine causes the formation of specific immunity in humans against avian influenza A. The protective effect of the vaccine, as a rule, occurs 21 days after the second vaccination.

Pharmacokinetics:

No data.

Indications:

FROMPecific prevention of avian influenza in humans.

Vaccination is recommended for people aged 18 to 60 due to epidemiological indications.

XXI.Z20-Z29.Z25.1   The need for immunization against influenza

Contraindications:

Acute infectious and non-infectious diseases; chronic diseases in the stage of exacerbation or decompensation; hypersensitivity to chicken protein; response or post-vaccination complication to previous administration of seasonal influenza vaccines; immunodeficiency status (primary), immunosuppression, malignant neoplasms; diseases of the nasopharynx in the acute stage; pregnancy and the period of breastfeeding.

Carefully:

The grafted should be in a sitting position with a slightly upturned head.After vaccine administration, the vaccine should remain in a sitting position with a slightly tilted head for 1 minute. Dissolved vaccine should be used within 30 minutes.

Pregnancy and lactation:

Contraindicated in pregnancy, during lactation.

Dosing and Administration:

The vaccine is administered intranasally two times with an interval of 10 days by means of a dispenser - dispenser (RD).

Immediately before vaccination, the contents of the ampoule are dissolved at room temperature in 0.5 ml of the solvent included in the vaccine kit. The vaccine should completely dissolve within three minutes. Dissolved drug - colorless, slightly opalescent liquid.

It is not suitable to use the drug in ampoules with broken integrity, marking, as well as changing its physical properties (color, transparency), with improper storage.

The vaccine is injected into the nasal passages at a rate of 0.25 ml per each nasal opening. To administer the vaccine in the form of a finely divided mixture, a sterile syringe, a sterile needle and one removable nozzle single use, included in the kit vaccine.

The spray tip is injected to a depth of 0.5 cm into the nasal passages, previously cleaned of mucus. The grafted should be in a sitting position with a slightly upturned head. After vaccine administration, the vaccine should remain in a sitting position with a slightly tilted head for 1 minute. Dissolved vaccine should be used within 30 minutes.

Method of use for vaccination:

1. Put the needle on the syringe, fill it with a solvent (water for injections) of room temperature, included in the vaccine kit, in a volume of 0.5 ml.

2. For dissolution, fill the opened ampoule with the vaccine with a solvent from the syringe.

3. After dissolution, fill the syringe with 0.5 ml (mark 20 on a scale of 80 units or mark 50 on a scale of 100 units).

4. Remove the needle and put on a tightly detachable nozzle (spray tip).

5. Bring the nozzle tip close to the nasal passage and squeeze the vaccine into each nasal passage of 0.25 ml with sharp pressure on the syringe plunger.

Side effects:

After vaccination for 4 days, some vaccinated people may have: an increase in temperature to 37.5 ° C, malaise, headache, minor catarrhal phenomena.The presence of reactions with an increase in temperature above 37.5 ° C is not more than 2% of the vaccinated. The duration of the temperature reaction should not exceed 3 days.

Overdose:

No data.

Interaction:

Not installed.

Special instructions:

All persons subject to vaccinations should be examined by a physician (paramedic), taking into account anamnestic data. On the day of vaccination, the vaccinated should be examined by a physician (paramedic) with obligatory thermometry. At a temperature above 37 ° C vaccinations are not carried out. The doctor (paramedic) is responsible for the correct appointment of the vaccine. The vaccine is recorded in the prescribed registration forms with the date, the manufacturer of the drug, the serial number, the reaction to the vaccination.

Acute infectious and non-infectious diseases are temporary contraindications for vaccination. Vaccination is carried out 2-4 weeks after recovery. For non-severe acute respiratory viral infections, acute intestinal diseases and others, the vaccine is given after the temperature is normalized.

Instructions
Up